tetano
Editor, Senior Moderator
Emerg Infect Dis. 2011 Aug;17(8):1472-4.
Multidrug-Resistant Pandemic (H1N1) 2009 Infection in Immunocompetent Child.
Eshaghi A, Patel SN, Sarabia A, Higgins RR, Savchenko A, Stojios PJ, Li Y, Bastien N, Alexander DC, Low DE, Gubbay JB.
Source
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada.
Abstract
Recent case reports describe multidrug-resistant influenza A pandemic (H1N1) 2009 virus infection in immunocompromised patients exposed to neuraminidase inhibitors because of an I223R neuraminidase mutation. We report a case of multidrug-resistant pandemic (H1N1) 2009 bearing the I223R mutation in an ambulatory child with no previous exposure to neuraminidase inhibitors.
PMID:
21801626
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21801626
Multidrug-Resistant Pandemic (H1N1) 2009 Infection in Immunocompetent Child.
Eshaghi A, Patel SN, Sarabia A, Higgins RR, Savchenko A, Stojios PJ, Li Y, Bastien N, Alexander DC, Low DE, Gubbay JB.
Source
Ontario Agency for Health Protection and Promotion, Toronto, Ontario, Canada.
Abstract
Recent case reports describe multidrug-resistant influenza A pandemic (H1N1) 2009 virus infection in immunocompromised patients exposed to neuraminidase inhibitors because of an I223R neuraminidase mutation. We report a case of multidrug-resistant pandemic (H1N1) 2009 bearing the I223R mutation in an ambulatory child with no previous exposure to neuraminidase inhibitors.
PMID:
21801626
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21801626